This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global hemostasis products market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global hemostasis products market.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Based on product type, the global hemostasis products market has been segmented into topical hemostasis products (collagen, oxidized regenerated cellulose, gelatin, and polysacchride), infusible hemostasis products (platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex), and advanced hemostasis products (flowable, thrombin, fibrin, and synthetic sealants). The market has been further studied from the point of view of major applications of hemostasis products.
Based on application, the market has been categorized into trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Based on end-user, the market has been segmented into hospitals and clinics.
Geographically, the global hemostasis products market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S, Canada, the U.K., Germany, Japan, China, Brazil, and Mexico. The report also profiles major players in the hemostasis products market based on various attributes such as company overview, financial overview, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., C. R. Bard, Inc., CSL Behring LLC, Grifols, S.A., HemCon Medical Technologies, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, and Pfizer, Inc.